ANNUAL CONFERENCE 2018

Safe medication management in the vulnerable senior population and the avoidance of preventable medication errors during care transitions are building blocks of value-based care. Consultant pharmacists and medical directors are vital players in improving medication safety practices during these transitions to improve quality, reduce adverse drug events, prevent re-hospitalizations, and increase patient satisfaction. Join ASCP and AMDA leadership as they discuss how recent regulatory and legislative efforts affect transitions of care, how medications contribute to rehospitalizations, and how a collaborative effort between the medical director, consultant pharmacist, and facility staff can avoid readmissions. .

Learning Objectives:
(1) Explain how the Impact Act and Mega-Rule affect transitions of care.
(2) Describe potential financial penalties for skilled nursing facilities.
(3) Describe how medications contribute to the frequency of re-hospitalizations.
(4) Discuss how pharmacists, physicians, and other facility team members can collaborate to reduce hospital re-admissions.